14.63
-0.13 (-0.88%)
Previous Close | 14.76 |
Open | 14.74 |
Volume | 753,892 |
Avg. Volume (3M) | 2,205,729 |
Market Cap | 1,493,913,216 |
Price / Book | 5.76 |
52 Weeks Range | |
Earnings Date | 11 Aug 2025 |
Diluted EPS (TTM) | -9.25 |
Total Debt/Equity (MRQ) | 13.68% |
Current Ratio (MRQ) | 2.33 |
Operating Cash Flow (TTM) | -644.94 M |
Levered Free Cash Flow (TTM) | -394.10 M |
Return on Assets (TTM) | -129.99% |
Return on Equity (TTM) | -316.82% |
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (US) | Mixed | Bearish |
Biotechnology (Global) | Mixed | Bearish | |
Stock | Biohaven Ltd. | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | 3.0 |
Insider Activity | NA |
Price Volatility | 4.5 |
Technical Moving Averages | 1.0 |
Technical Oscillators | -2.0 |
Average | 1.63 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others. |
|
Sector | Healthcare |
Industry | Biotechnology |
Investment Style | Small Core |
% Held by Insiders | 11.96% |
% Held by Institutions | 90.75% |
Ownership
Name | Date | Shares Held |
---|---|---|
Suvretta Capital Management, Llc | 31 Dec 2024 | 5,620,271 |
Bellevue Group Ag | 31 Dec 2024 | 2,040,853 |
52 Weeks Range | ||
Price Target Range | ||
High | 57.00 (Baird, 289.61%) | Buy |
Median | 55.00 (275.94%) | |
Low | 21.00 (RBC Capital, 43.54%) | Hold |
Average | 44.33 (203.01%) | |
Total | 2 Buy, 1 Hold | |
Avg. Price @ Call | 17.29 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
JP Morgan | 18 Jun 2025 | 55.00 (275.94%) | Buy | 14.39 |
RBC Capital | 19 May 2025 | 21.00 (43.54%) | Hold | 15.75 |
13 May 2025 | 54.00 (269.10%) | Buy | 19.51 | |
Baird | 28 Apr 2025 | 57.00 (289.61%) | Buy | 21.74 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |